Serum proteins mediate depression's association with dementia

PLoS ONE

Volumn 12, Issue 6, 2017, Pages

  Royall, Donald R ^a,b,c   Al Rubaye, Safa ^a   Bishnoi, Ram ^d   Palmer, Raymond F ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c S Texas Vet' Hlth Syst Audie L Murphy Div Geriatric Res Education and Clinical Care Center   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN E; EPIDERMAL GROWTH FACTOR; HEMOGLOBIN A1C; HOMOCYSTEINE; LUTEINIZING HORMONE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN S100B; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER; PLASMA PROTEIN; RESISTIN;

AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; BLOOD; COMPLICATION; METABOLISM;

AGED; BIOMARKERS; BLOOD PROTEINS; DEMENTIA; DEPRESSION; HUMANS; RESISTIN;

EID: 85020422982     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175790     Document Type: Article

References (64)

1. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatr 2006; 63: 530-8 https://doi.org/10.1001/archpsyc.63.5.530 PMID: 16651510
2. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatr 2007; 22: 563-7.
3. Royall DR, Palmer RF. Alzheimer pathology does not mediate the association between depressive symptoms and subsequent cognitive decline. Alz Dis & Dementia 2013; 9: 318-25.
4. Degenhardt EK, Witte MM, Case MG, Yu P, Henley DB, Hochstetler HM, et al. Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia. Psychosomatics 2016; 57: 208-16. https://doi.org/10.1016/j.psym.2015.12.002 PMID: 26892326
5. Landau SM, Horng A, Fero A, Jagust WJ. Alzheimer's Disease Neuroimaging Initiative. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. Neurology 2016; 86: 1377-1385. https://doi.org/10.1212/WNL.0000000000002576 PMID: 26968515
6. Sheline YI, West T, Yarasheski K, Swarm R, Jasielec MS, Fisher JR, et al. An antidepressant decreases CSF Aβ production in healthty individuals and in transgenic AD mice. Sci Transl Med 2014; 6: 236re4. https://doi.org/10.1126/scitranslmed.3008169 PMID: 24828079
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders ( Fifth ed.). Arlington, VA: American Psychiatric Publishing, 2013.
8. Spearman C. General intelligence, objectively determined and measure. Am J Psychol 1904; 15, 201-93.
9. Royall DR, Palmer RF. "Executive functions" cannot be distinguished from general intelligence: Two variations on a single theme within a symphony of latent variance. Front Behav Neurosci 2014; 9: 1-10.
10. Royall DR, Palmer RF, O'Bryant SE. Validation of a latent variable representing the dementing process. J Alz Dis 2012; 30: 639-49.
11. Gavett BE, Vudy V, Jeffrey M, John SE, Gurnani A, Adams J. The δ latent dementia phenotype in the NACC UDS: Cross-validation and extension. Neuropsychol 2015; 29: 344-352.
12. Palmer RF, Royall DR. Future dementia status is almost entirely explained by the latent variable δ's intercept and slope. J Alz Dis 2016; 49: 521-29.
13. Royall DR, Palmer RF, Matsuoka T, Kato Y, Taniguchi S, Ogawa M, et al. Greater than the sum of its parts: δ scores are exportable across cultural and linguistic boundaries. J Alz Dis 2016; 49: 561-70.
14. Royall DR, Palmer RF, Markides KS. Exportation and validation of latent constructs for dementia casefinding in a Mexican-American Population-based Cohort. J Gerontol: Series B: Psychol Sci 2017, in press.
15. Royall DR, Palmer RF. δ Scores predict MCI and AD conversions from non-demented states. Alz & Dem: Diagnosis Assessment and Disease Management, 2017; 6: 214-221.
16. Royall DR, Palmer RF. Aging is a weak but relentless determinant of dementia severity. Oncotarget 2016; 7: 13307-13318. https://doi.org/10.18632/oncotarget.7759 PMID: 26930722
17. Royall DR, Al-Rubaye S, Bishnoi R, Palmer RF. Serum protein mediators of dementia and Aging Proper. Aging 2016; 8: 3241-3254. https://doi.org/10.18632/aging.101091 PMID: 27922822
18. Royall DR, Al-Rubaye S, Bishnoi R, Palmer RF. Few serum proteins mediate APOE's association with dementia. PLoS One. 2017; 12:e0172268. https://doi.org/10.1371/journal.pone.0172268 PMID: 28291794
19. McKhann D, Drockman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group. Neurology. 1984; 34:939-944. PMID: 6610841
20. Wechsler D. Wechsler Memory Scale - Third Edition. San Antonio, TX: The Psychological Corporation, 1997.
21. Benton A, Hamsher K. Multilingual Aphasia Examination. AJA Associates, Iowa City, Iowa, 1989.
22. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86. PMID: 5349366
23. Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Muller J, Schomig A, et al. TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E. Clin Chem Lab Med 2002; 40: 1123-31. https://doi.org/10.1515/CCLM.2002.197 PMID: 12521230
24. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-72. PMID: 7104545
25. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al., (1982): Development and validation of a geriatric depression screening scale: A preliminary report. J Am Geriatr Soc 1982; 29: 164-71.
26. Mitchell AJ, Bird V, Rizzo M, Meader N. Which version of the Geriatric Depression Scale is most useful in medical settings and nursing homes? Diagnostic validity meta-analysis. Am J Geriatr Psychiatr 2010; 18: 1066-77.
27. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res, 1975; 12;189-198.
28. Waring S, O'Bryant SE, Reisch JS, Diaz-Arrastia R, Knebl J, Doody R, for the Texas Alzheimer's Research Consortium. The Texas Alzheimer's Research Consortium longitudinal research cohort: Study design and baseline characteristics. Tex Public Health J 2008; 60: 9-13.
29. Arbuckle, JL. Analysis of Moment Structures-AMOS (Version 7.0) [Computer Program], SPSS, Chicago, 2006.
30. Royall DR, Palmer RF. Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites. Alz Dement: Diagnosis, Assessment & Disease Monitoring 2016; 3: 35-42.
31. Grice JW. Computing and evaluation factor scores. Psychol Methods 2001; 6: 430-50. PMID: 11778682
32. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatr 2001; 158: 848-56 https://doi.org/10.1176/appi.ajp.158.6.848 PMID: 11384888
33. MacKinnon D. Analysis of mediating variables in prevention and intervention research. In: Czarees A, Beatty L (editors). Scientific methods for prevention intervention research. NIDA Research Monograph 1994; 139: 137-53.
34. Metz CE. Basic principles of ROC analysis. Sem Nucl Med 1978; 8: 283-98.
35. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77. PMID: 8472349
36. Palmer RF, Royall DR. Missing data? Plan on it! J Am Geriatr Soc 2010; 58: S343-48. https://doi.org/10.1111/j.1532-5415.2010.03053.x PMID: 21029065
37. Schafer JL, Graham JW. Missing data: Our view of the state of the art. Psychol Methods 2002; 7: 147-77. PMID: 12090408
38. Graham JW. Missing Data Analysis: Making it work in the real world. Ann Rev Psychol 2009; 6: 549-76.
39. PASW Statistics 18, Release Version 18.0.0, SPSS, Inc., Chicago, IL, 2009.
40. Bollen KA, Long JS. Testing Structural Equation Models. Sage Publications, Thousand Oaks, CA. 1993.
41. Wheaton B, Muthén B, Alwin DF, Summer GF. Assessing reliability and stability in panel models. In Heise DR (Ed.) Sociology Methodology San Francisco, CA: Jossey-Bass. 1977.
42. Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990; 107: 238-46. PMID: 2320703
43. Browne M, Cudeck R. Alternative ways of assessing model fit. In Testing structural equation models, Bollen KA, Long JS, eds. Sage Publications, Thousand Oaks, CA, pp. 136-62, 1993.
44. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, et al. Assessment of a multiassay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 2013; 18: 332-339. https://doi.org/10.1038/mp.2011.166 PMID: 22158016
45. Bilello JA, Thurmond LM, Smith KM, Pi B, Rubin R, Wright SM, et al. MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder. J Clin Psychiatry 2015; 76: e199-206. https://doi.org/10.4088/JCP.14m09029 PMID: 25742207
46. Schroeter ML, Sacher J, Steiner J, Schoenknecht P, Mueller K. Serum S100B represents a new biomarker for mood disorders. Current Drug Targets 2013; 14: 1237-48. https://doi.org/10.2174/ 13894501113149990014 PMID: 23701298
47. Marinho PE, Castro CM, Raposo MC, Guerra RO, de Andrade AD. Depressive symptoms, inflammatory markers and body composition in elderly with and without chronic obstructive pulmonary disease (COPD). Arch Gerontol Geriatr 2012; 54: 453-8. https://doi.org/10.1016/j.archger.2011.05.006 PMID: 21636137
48. Lee JG, Shin BS, You YS, Kim JE, Yoon SW, Jeon DW, et al. Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia. Psychiatr Investig 2009; 6: 299-305.
49. Royall DR, Palmer RF. Ethnicity moderates dementia's biomarkers. J Alz Dis, 2015; 43:275-287.
50. Bishnoi R, Palmer RF, Royall DR. IL-15 as a serum biomarker of Alzheimer Disease. PLoS One, 2015; 10:e0117282.51.
51. Bishnoi R, Palmer RF, Royall DR. Vitamin D Binding Protein as a serum biomarker of Alzheimer Disease. J Alz Dis, 2015; 43:37-45.
52. Pláteník J, Fišar Z, Buchal R, Jirák R, Kitzlerová E, Zvěřová M, et al. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression. Prog Neuropsychopharmacol Biol Psychiatr 2012; 50: 83-93.
53. Bemelmans KJ, Noort A, de Rijk R, Middelkoop HA, van Kempen GM, Goekoop JG. Plasma cortisol and norepinephrine in Alzheimer's disease: opposite relations with recall performance and stage of progression. Acta Neuropsychiatr 2007; 19: 231-237. https://doi.org/10.1111/j.1601-5215.2006.00172.x PMID: 26952889
54. T'Sjoen GG, De Vos S, Goemaere S, Van Pottelbergh I, Dierick M, Van Heeringen C, et al. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc 2005; 53: 636-642. https://doi.org/10.1111/j.1532-5415.2005.53212.x PMID: 15817010
55. Hogervorst E, Combrinck M, Smith AD. Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett 2003; 24: 203-208. PMID: 14523358
56. Royall DR, Palmer RF, Vidoni ED, Honea RA, Burns JM. The Default Mode Network and related right hemisphere structures may be the key substrates of dementia. J Alz Dis 2012; 32: 467-78. 57.
57. Royall DR, Palmer RF, Vidoni ED, Honea RA. The Default Mode Network may be the Key Substrate of Depression Related Cognitive Changes. J Alz Dis 2013; 34: 547-60.
58. Thompson WH, Thelin EP, Lilja A, Bellander BM, Fransson P. Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury. Neuroimage: Clin 2016; 12: 1004-12.
59. Kennedy N, Foy F, Sherazi R, McDonough M, McKeon P. Long-term social functioning after depression treated by psychiatrists: A review. Bipolar Disord 2007; 9: 25-37. https://doi.org/10.1111/j.1399-5618. 2007.00326.x PMID: 17391347
60. Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neuro-cognitive deficits and disability in major depressive disorder. Psychiatr Res 2006; 145: 39-48.
61. Royall DR, Al-Rubaye S, Bishnoi R, Palmer RF. Serum protein biomarkers of δ fully mediate multiple AD conversion risks and offer targets for intervention [abstract]. J Prev Alz Dis. 2016; 3,283.
62. Kizilarslanoǧlu MC, Kara Ö , Yeşil Y, Kuyumcu ME, Öztürk ZA, Cankurtaran M, et al. Alzheimer disease, inflammation, and novel inflammatory marker: resistin. Turk J Med Sci. 2015; 45:1040-1046. PMID: 26738345
63. Weber-Hamann B, Kratzsch J, Kopf D, Lederbogen F, Gilles M, Heuser I, et al. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. J Psychiatric Res. 2007; 41:344-350.
64. John SE, Gurnani AS, Bussell C, Saurman JL, Griffin JW, Gavett BE. The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the Uniform Data Set. Neuropsychol. 2016; 30: 946-960.